Added to YB: 2026-03-23
Pitch date: 2026-03-19
NRXS [neutral]
NeurAxis, Inc.
Author Info
Microcap Opportunities is a community dedicated to finding the best opportunities in the MicroCap space for US and Canadian listings primarily. Sign up for the newsletter.
Company Info
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
Market Cap
$74.5M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-9.12
P/E
-7.36
EV/Sales
19.59
Sector
Health Care Equipment and Supplies
Category
growth
NeurAxis - Last Call Before Full Commercialization Numbers Are Reported
NRXS (update): Q1 2026 prior auths up 10x YoY vs Q1 2025 rev of $896K; even at 30% conversion = $2.5M-$4M Q1 vs $3.6M FY25 total. Category I CPT code (effective Jan 1) unlocked reimbursement. 24 insurers covering ~100M lives; VA channel ramping. Base case: $10.5M run rate (commercial $5.7M + VA $4.8M). Bull: $53M. $7.2M cash, minimal debt, 15.4M FD shares. Awaiting Q1 results.
Read full article (8 min)